Does anybody have info on why the downgrade today (i.e., an analyst report/update)? My 2 cents - I still see upside with earnings in a few weeks with Intl growth, SGA cost reductions and the Olympus settlement. Long-term - strong balance sheet, recent M&A activity in the bio/pharma space...would like to better understand where they are w FDA filing for Colon pillcam.
<I have never even heard of oscar the grouch securities.> me either...they seem like a small outfit, but would like to read their analyst report (if any) on the downgrade. Nice movement today with above avg volume.